The detailed information for PTAB case with proceeding number IPR2017-02066 filed by Coherus BioSciences, Inc. against Hoffmann-La Roche Inc. et al. on Sep 7, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2017-02066
Filing Date
Sep 7, 2017
Petitioner
Coherus BioSciences, Inc.
Respondent
Hoffmann-La Roche Inc. et al.
Status
Institution Denied
Respondent Application Number
08444790
Respondent Tech Center
1600
Respondent Patent Number
8063182
Institution Decision Date
Mar 9, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Sep 19, 2018PAPERBOARD

Petitioner's Request for Refund of Post-Institution Fees

Aug 8, 2018PAPERPETITIONER

Decision Denying Petitioner's Request for Rehearing

Jul 13, 2018PAPERBOARD

Granting Patent Owner's Motion to Expunge

Jul 13, 2018PAPERBOARD

Coherus Biosciences, Inc.'s Request for Rehearing

Apr 9, 2018PAPERPETITIONER

Patent Owner's Motion to Expunge

Mar 23, 2018PAPERPATENT OWNER

Decision Denying Institution of Inter Partes Review

Mar 9, 2018PAPERBOARD

Petitioner's Submission of Transcript of January 3, 2018 Conference Call

Jan 9, 2018PAPERPETITIONER

PETITIONER¿¿¿S NOTICE OF DESIGNATION OF ADDITIONAL BACK-UP COUNSEL

Dec 27, 2017PAPERPETITIONER

Patent Owner Preliminary Response

Dec 15, 2017PAPERPATENT OWNER

Ex. 2001 - Declaration of Michael Croft, Ph.D.

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2003 - Coherus 10-K

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2004 - Enbrel Label (Nov. 2017)

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2007 - Molta 2007

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2011 - Huck 1986

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2012 - Kabat 1987

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2014 - Sakano 1979

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2002 - Croft CV

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2005 - Schmidt 2017

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2006 - Etanercept - DrugBank

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2009 - Loetscher 1990

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2010 - Schall 1990

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2013 - Takahashi 1982

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2015 - Ellison & Hood 1982

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2017 - Morrison 1985

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2018 - WO8909622A1

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2021 - Engelmann 1989

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2024 - Kohno 2005 (Color)

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2025 - Kohno 2007

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2028 - Bruggemann 1987

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2031 - 2.23.2007 Final Rejection

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2016 - Heller 1990

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2019 - EP0315062A2

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2020 - Gregersen 1990

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2022 - Hohmann 1989

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2023 - Thomas 1985

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2026 - Arora 2009

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2027 - CDER FDA GP2015 Summary Review

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2029 - Coherus Press Release

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2030 - FDA AAC Transcript

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2032 - Moreland 2000

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2034 - 3.7.2011 Non-Final Rejection

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2038 - Scientific Considerations

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2040 - Jacob 1989

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2044 - Brockhaus 1990

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2046 - Declaration of Roy M. Fleischmann, M.D.

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2047 - Fleischmann CV 12.12.2017

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2048 - Gibofsky 2012

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2033 - Quality Considerations

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2035 - 8.31.2011 Notice of Allowance

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2039 - Lipsky 1989

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2041 - Huston 1988

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2042 - 866 Patent

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2043 - Katre 1990

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2045 - 3.24.2009 Ex. Answer

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2050 - Wolfe

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2051 - Aggarwal

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2052 - Asherson 1991

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2053 - Maxwell 1994

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2055 - Weinblatt 2013

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2049 - Harris 1990

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2054 - Cash 1994

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2056 - Weinblatt 1999

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2057 - Feldmann; 2002

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2058 - Amgen - Investors - Press Release

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2063 - Geiger 1998

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2065 - Immunex Press Release Sep 1998

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2066 - FDA Approval Letter

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2069 - Fleischmann 2004

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2070 - Immunex Says Enbrel Shortage Worse Than Anticipated - latimes

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2071 - Timmerman (4. 2002)

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2072 - Genovese 2002

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2074 - O'Dell 1999

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2059 - Moreland 1996

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2060 - Moreland 1997

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2061 - Moreland et al; 1999

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2062 - Bathon 2000

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2064 - Thomas 1998

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2067 - Curtis 2011

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2068 - Beck 2011

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2073 - Alldred; 2001

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2075 - Pisetsky 2000

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2076 - Hamilton; 2000

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2077 - Ricks 1997

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2078 - Radiograph

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2079 - Moreland; 1998

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2084 - Andrew Carter CV

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2086 - Enbrel Label 1998

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2087 - Enbrel Label 2008.3

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2088 - Remicade Label 1999

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2090 - Remicade Label 2007.06

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2036 - Coherus Investor Slides

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2037 - 8.11.2011 Response

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2080 - Kerensky 2012

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2081 - van Vollenhoven et al; 2009

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2083 - Declaration of Andrew W. Carter - PROTECTIVE ORDER MATERIAL

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2085 - Palmer

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2089 - Remicade Label 2017.10

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2008 - Sandoz GP2015 FDA Advisory Committee Slides

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2091 - Morrow Johnson & Johnson to Acquire Centocor

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2093 - Humira Label 2017.4

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2094 - Humira Label 2008.2

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2095 - Slud - Feb

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2097 - Prescription information - PROTECTIVE ORDER MATERIAL

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2092 - Humira Label 2002.12

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2096 - Niles

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2099 - Desai 2017

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2101 - Zhang

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2108 - FDA Arthritis Advisory Committee Briefing Document (7.13.2016)

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2111 - Redacted Copy of Ex. 2083

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2113 - 11.10.2006 Response

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2100 - Ward

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2102 - ENBREL Ad (1998)

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2103 - Enbrel TV Ad (2004)

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2107 - CD4 IgG - AdisInsight

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2109 - 3.29.2011 Response

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2110 - 3.15.2011 Response

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2112 - Redacted Copy of Ex. 2097

Dec 15, 2017EXHIBITPATENT OWNER

Ex. 2114 - 11.09.2006 Lesslauer Declaration

Dec 15, 2017EXHIBITPATENT OWNER

Motion to Seal Exhibits 2083 and 2097 to IPR2017-02066

Dec 15, 2017PAPERPATENT OWNER

Patent Owner's Mandatory Notices

Sep 28, 2017PAPERPATENT OWNER

Patent Owner Hoffman-La Roche Inc.'s Power of Attorney

Sep 28, 2017PAPERPATENT OWNER

Real Parties in Interest Immunex Corporation, Amgen Manufacturing Ltd. and Amgen Inc.'s Power of Attorney

Sep 28, 2017PAPERPATENT OWNER

Notice of Accord Filing Date

Sep 26, 2017PAPERBOARD

Appeal Brief filed in App. No. 08/444,790 - PART 3

Sep 7, 2017EXHIBITPETITIONER

CH Patent Application Serial No. 3319-89

Sep 7, 2017EXHIBITPETITIONER

Dembic et al., Cytokine (1990)

Sep 7, 2017EXHIBITPETITIONER

U.S. Patent No. 5,116,964, Capon et al.

Sep 7, 2017EXHIBITPETITIONER

Petition, IPR2015-01792

Sep 7, 2017EXHIBITPETITIONER

U.S. Patent No. 6,004,781, Seed

Sep 7, 2017EXHIBITPETITIONER

Petition to Institute an Inter Partes Review of U.S. Patent No. 8,063,182 under 37 C.F.R. 42.100 et seq.

Sep 7, 2017PAPERPETITIONER

Petitioner's Power of Attorney Pursuant to 37 C.F.R. 42.10(b) for Petition for Inter Partes Review

Sep 7, 2017PAPERPETITIONER

U.S. Patent No. 8,163,522 (Brockhaus)

Sep 7, 2017EXHIBITPETITIONER

Burton Declaration

Sep 7, 2017EXHIBITPETITIONER

Watson et al., J. Cell Bio. (1990)

Sep 7, 2017EXHIBITPETITIONER

U.S. Patent No. 5,395,760 (Smith)

Sep 7, 2017EXHIBITPETITIONER

Zettlmeissl et al., DNA and Cell Biology (1990)

Sep 7, 2017EXHIBITPETITIONER

Appeal Brief filed in App. No. 08/444,790 - PART 1

Sep 7, 2017EXHIBITPETITIONER

Appeal Brief filed in App. No. 08/444,790 - PART 2

Sep 7, 2017EXHIBITPETITIONER

Appeal Brief filed in App. No. 08/444,790 - PART 4

Sep 7, 2017EXHIBITPETITIONER

Smith et al., Science (1990)

Sep 7, 2017EXHIBITPETITIONER

Patent Owner Preliminary Response, IPR2015-01792

Sep 7, 2017EXHIBITPETITIONER

Physicians' Desk Reference entry for for Enbrel (2002)

Sep 7, 2017EXHIBITPETITIONER

Decision Denying Institution of IPR, IPR2015-01792

Sep 7, 2017EXHIBITPETITIONER

European Patent Application No. 90107393.2

Sep 7, 2017EXHIBITPETITIONER

European Patent Application No. 90116707.2

Sep 7, 2017EXHIBITPETITIONER

CH Patent Application Serial No. 1347-90

Sep 7, 2017EXHIBITPETITIONER

CH Patent Application Serial No. 0746-90

Sep 7, 2017EXHIBITPETITIONER

Lesslauer Declaration, Dec. 13, 2004, App. No. 08/444,791

Sep 7, 2017EXHIBITPETITIONER

Lesslauer Declaration, Dec. 13, 2004, App. No. 08/444,791

Sep 7, 2017EXHIBITPETITIONER

U.S. Patent No. 5,428,130, Capon et al.

Sep 7, 2017EXHIBITPETITIONER

Arora Declaration, Dec. 16, 2010, App. No. 08/444,790

Sep 7, 2017EXHIBITPETITIONER

Affidavit of Spencer J. Johnson - August 1, 2017

Sep 7, 2017EXHIBITPETITIONER

Weaver Declaration regarding Watson et al., J. Cell Bio. (1990)

Sep 7, 2017EXHIBITPETITIONER

Debord Declaration regarding Zettlmeissl et al., DNA and Cell Biology (1990)

Sep 7, 2017EXHIBITPETITIONER

U.S. Patent No. 8,063,182 (Brockhaus)

Sep 7, 2017EXHIBITPETITIONER

Capon et al., Nature (1989)

Sep 7, 2017EXHIBITPETITIONER

Byrn et al., Nature (1990)

Sep 7, 2017EXHIBITPETITIONER

Brennan et al., The Lancet (1989)

Sep 7, 2017EXHIBITPETITIONER

Traunecker et al., Nature (1989)

Sep 7, 2017EXHIBITPETITIONER

Smith & Baglioni, J. Biol. Chem. (1987)

Sep 7, 2017EXHIBITPETITIONER

Smith & Baglioni, J. Biol. Chem. (1989)

Sep 7, 2017EXHIBITPETITIONER

Karush, Contemporary Topics in Molecular Immunology (1976)

Sep 7, 2017EXHIBITPETITIONER

Greenbury et al., Immunology (1965)

Sep 7, 2017EXHIBITPETITIONER

Mohler et al., J. Immunol. (1993)

Sep 7, 2017EXHIBITPETITIONER

Blank et al., J. Immunol. (1972)

Sep 7, 2017EXHIBITPETITIONER

Schneider et al., Proc. Nat'l Acad. Sci. USA (1988)

Sep 7, 2017EXHIBITPETITIONER

Oi et al., Nature (1984)

Sep 7, 2017EXHIBITPETITIONER

Gregory et al., Molecular Immunology (1987)

Sep 7, 2017EXHIBITPETITIONER

Lachmann et al., Springer Semin Immunopathol (1984)

Sep 7, 2017EXHIBITPETITIONER

Kohno et al., Amgen Inc. (2005)

Sep 7, 2017EXHIBITPETITIONER

Khare et al., Amgen Inc. (2005)

Sep 7, 2017EXHIBITPETITIONER

Mitoma et al., Arthritis & Rheumatism (2008)

Sep 7, 2017EXHIBITPETITIONER

FDA Drug Safety Communication (Sept. 7, 2011)

Sep 7, 2017EXHIBITPETITIONER

Ellison et al., Nucleic Acids Research (1982)

Sep 7, 2017EXHIBITPETITIONER

Jayapal et al., Chemical Engineering Procress (2007)

Sep 7, 2017EXHIBITPETITIONER

Klinman, J. Immunol (1967)

Sep 7, 2017EXHIBITPETITIONER

Parekh et al., Landes Bioscience (2012)

Sep 7, 2017EXHIBITPETITIONER

Arend & Dayer, Arthritis & Rheumatism (1990)

Sep 7, 2017EXHIBITPETITIONER

Engelmann et al., J. Biol. Chem. (1990)

Sep 7, 2017EXHIBITPETITIONER

Amgen - Press Release

Sep 7, 2017EXHIBITPETITIONER

Reply Appeal Brief filed in App. No. 08/444,790

Sep 7, 2017EXHIBITPETITIONER

Amendment, Dec. 16, 2010, App. No. 08/444,790

Sep 7, 2017EXHIBITPETITIONER

Loumaye, Endocrinology (1982)

Sep 7, 2017EXHIBITPETITIONER

Gliemann et al., Diabetologia (1974)

Sep 7, 2017EXHIBITPETITIONER

Beutler, Ann. Rev. Biochem. (1988)

Sep 7, 2017EXHIBITPETITIONER

Notice of Allowance, Aug. 31, 2011, App. No. 08/444,790

Sep 7, 2017EXHIBITPETITIONER

Supplemental Amendment, Nov. 14, 2006, App. No. 08444,790

Sep 7, 2017EXHIBITPETITIONER

Third Lesslauer Declaration, Nov. 14, 2006, App. No. 08/444,790

Sep 7, 2017EXHIBITPETITIONER

Application, Sept. 10, 1990, App. No. 07/580,013

Sep 7, 2017EXHIBITPETITIONER